Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications drug pricing reform efforts blueprint turns 1 year old
… How Do We Get Drug Labeling Based on Patient Reported Outcomes? With Ari …
… if: The dosing regimen changes from 3 times a day to 1? Length of treatment decreases to 5 days instead of 10? The … approach to WTP ensures actionable results to inform your drug development and market access strategies. For your …
… Behavioral Risk Factor Surveillance System (BRFSS) CPRD Drug Abuse Warning Network Friuli-Venezia-Giulia databases GE … National Nursing Home Survey (NNHS) National Survey On Drug Use and Health (NSDUH) Organ Procurement and …
… or coauthored more than 450 peer-reviewed scholarly publications. He is a former president of the Society for …
… of capmatinib initially reported in the GEOMETRY mono-1 trial. Because the effectiveness of capmatinib shown in …
… questions—whether the results will be used to inform your drug development and post-approval strategies or place a … projects such as regulatory submissions (e.g. Orphan Drug Applications, Pediatric Investigation Plans, … references, with some review articles Typical Timelines* 1-2 Months 1-4 Months 4-9+ Months *Timelines vary due to the …
… FDA Guidance In June 2018, the United States Food and Drug Administration (US FDA) released an important guidance … clearance, or licensure of the product or new use Product pricing information Patient utilization projections (e.g., … from Phase 1, Phase 2, and Phase 3 studies (peer-reviewed publications; congress abstracts, posters, and presentations; …
Knowledgebase - ICER Evaluations Image Image Image Knowledgebase KB Image Image KB …
About As a business unit of RTI International , we provide global biopharmaceutical companies research and consulting services in health economics, patient-centered outcomes research, market access, and pharmacoepidemiology. As the only non-profit, …
… that impact human health. For example, how does a 60-year-old physician from New York, who is statistically most … a person who lives in a small, rural region with only 1 community hospital compared with an urban-dwelling … diversity, inclusion, and belonging in patient centered drug development with patient preference research . Poulos …